Insilico Medicine is an artificial intelligence company located at the Emerging Technology Centers at the Johns Hopkins University Eastern campus in Baltimore, with R&D resources in 6 countries sourced through hackathons and competitions. The company specializes in the generative adversarial networks and reinforcement learning for drug discovery for age-related diseases with a pipeline of over one thousand high-value pre-clinical leads. Through its Pharma.AI division, Insilico provides the next-generation AI solutions to biotechnology, pharmaceutical, and skin care companies, foundations and national governments globally. In 2017, NVIDIA selected Insilico Medicine as one of the Top 5 AI social impact companies. The company is strongly committed to reducing or eliminating AI and human biases and openly exposes the challenges posed by AI in the healthcare industry.